Meeting
2023 ASCO Annual Meeting
Geographical impact on prostate cancer genetic testing eligibility: A preliminary study from an academic cancer center.
Authors
Samantha Beck
University of Utah, Salt Lake City, UT
Samantha Beck , Jonathan David Tward , Amanda Gammon , Samantha Greenberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10618)
DOI
10.1200/JCO.2023.41.16_suppl.10618
Abstract #
10618
Poster Bd #
251
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Using patient-reported outcomes to assess the impact of germline genetic testing on prostate cancer patients.
First Author: Sarah M. Nielsen
Poster
2023 ASCO Genitourinary Cancers Symposium
Real world rates of genetic referrals and germline testing in patients with prostate adenocarcinoma at an academic cancer center in southern New Jersey.
First Author: Christopher Ambrogi
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of pretest video genetic education in prostate cancer patients: Do patients need us?
First Author: Samantha Greenberg
Poster
2019 Genitourinary Cancers Symposium
Genetic counseling processes and outcomes among prostate cancer patients (ProGen).
First Author: Donna Rachel Vatnick